腦膜瘤表達抗原5(MGEA5)重組蛋白
Recombinant Meningioma Expressed Antigen 5 (MGEA5)
NAGase; MEA5; NCOAT; Hexosaminidase C; N-Acetylhexosaminidase; Hyaluronidase; Meningioma-Expressed Antigen 5; Nuclear Cytoplasmic O-GlcNAcase And Acetyltransferase
- 編號RPA069Hu02
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞質(zhì), 染色體
- 預測分子量15.5kDa
- 實際分子量20kDa(差異分析請參閱說明書)
- 片段與標簽Glu319~Thr450 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點5.0
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 912 ¥ 2280 ¥ 4560 ¥ 13680 ¥ 34200
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPA069Hu03 | 腦膜瘤表達抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA069Hu01 | 腦膜瘤表達抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA069Hu02 | 腦膜瘤表達抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA069Hu03 | 腦膜瘤表達抗原5(MGEA5)多克隆抗體 | WB; IHC; ICC; IP. |
PAA069Hu01 | 腦膜瘤表達抗原5(MGEA5)多克隆抗體 | WB,IHC,ICC/IF |
PAA069Hu02 | 腦膜瘤表達抗原5(MGEA5)多克隆抗體 | WB; IHC; ICC; IP. |
FAA069Hu01 | 抗腦膜瘤表達抗原5(MGEA5)多克隆抗體 | Flow cytometry. |
LAA069Hu71 | 腦膜瘤表達抗原5(MGEA5)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAA069Hu22 | 腦膜瘤表達抗原5(MGEA5)單克隆抗體 | WB; IHC; ICC; IP. |
SEA069Hu | 腦膜瘤表達抗原5(MGEA5)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA069Hu | 腦膜瘤表達抗原5(MGEA5)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA069Hu | 腦膜瘤表達抗原5(MGEA5)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Plos one | Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation [PubMed: PMC3677913] |
Renal Failure | Evaluation of the Process of Recycling and Renal Parenchymal Injury after ESWL with Metabolites Excreted in the Urine [Pubmed: 23413820] |
BioMed Research International | The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies [Hindawi: 740105] |
PLoS One | Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats [PubMed: 25909514] |
Ecotoxicol Environ Saf | Melamine and oxalate coexposure induces early kidney tubular injury through mitochondrial aberrations and oxidative stress [34507040] |
Antioxidants | Diminishment of Nrf2 Antioxidative Defense Aggravates Nephrotoxicity of Melamine and Oxalate Coexposure. Antioxidants 2021, 10, 1464 [34573096] |
留言咨詢